Joseph R Peterson
Overview
Explore the profile of Joseph R Peterson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
116
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Weitz M, Pfeiffer J, Patel S, Biancalana M, Pekis A, Kannan V, et al.
NPJ Breast Cancer
. 2024 Nov;
10(1):98.
PMID: 39543194
Surgery remains the primary treatment modality in the management of early-stage invasive breast cancer. Artificial intelligence (AI)-powered visualization platforms offer the compelling potential to aid surgeons in evaluating the tumor's...
2.
Peterson J, Cole J, Pfeiffer J, Norris G, Zhang Y, Lopez-Ramos D, et al.
Breast Cancer Res
. 2023 May;
25(1):54.
PMID: 37165441
Background: Generalizable population-based studies are unable to account for individual tumor heterogeneity that contributes to variability in a patient's response to physician-chosen therapy. Although molecular characterization of tumors has advanced...
3.
Cook D, Biancalana M, Liadis N, Lopez Ramos D, Zhang Y, Patel S, et al.
Front Artif Intell
. 2023 May;
6:1153083.
PMID: 37138891
Background: Immuno-oncology (IO) therapies targeting the PD-1/PD-L1 axis, such as immune checkpoint inhibitor (ICI) antibodies, have emerged as promising treatments for early-stage breast cancer (ESBC). Despite immunotherapy's clinical significance, the...
4.
Howard F, He G, Peterson J, Pfeiffer J, Earnest T, Pearson A, et al.
Breast Cancer Res Treat
. 2022 Sep;
196(1):57-66.
PMID: 36063220
Purpose: Pathologic complete response (pCR) to neoadjuvant chemotherapy (NAC) in early breast cancer (EBC) is largely dependent on breast cancer subtype, but no clinical-grade model exists to predict response and...
5.
Bianchi D, Peterson J, Earnest T, Hallock M, Luthey-Schulten Z
IET Syst Biol
. 2021 Jan;
12(4):170-176.
PMID: 33451183
It is well known that stochasticity in gene expression is an important source of noise that can have profound effects on the fate of a living cell. In the galactose...
6.
Ghaemi Z, Peterson J, Gruebele M, Luthey-Schulten Z
PLoS Comput Biol
. 2020 Mar;
16(3):e1007717.
PMID: 32210422
Spatial organization is a characteristic of all cells, achieved in eukaryotic cells by utilizing both membrane-bound and membrane-less organelles. One of the key processes in eukaryotes is RNA splicing, which...
7.
Peterson J, Cole J, Luthey-Schulten Z
PLoS One
. 2017 Dec;
12(12):e0190193.
PMID: 29261814
[This corrects the article DOI: 10.1371/journal.pone.0182570.].
8.
Peterson J, Cole J, Luthey-Schulten Z
PLoS One
. 2017 Aug;
12(8):e0182570.
PMID: 28820904
Characterizing the complex spatial and temporal interactions among cells in a biological system (i.e. bacterial colony, microbiome, tissue, etc.) remains a challenge. Metabolic cooperativity in these systems can arise due...
9.
Thor S, Peterson J, Luthey-Schulten Z
Archaea
. 2017 Jan;
2017:9763848.
PMID: 28133437
Decades of biochemical, bioinformatic, and sequencing data are currently being systematically compiled into genome-scale metabolic reconstructions (GEMs). Such reconstructions are knowledge-bases useful for engineering, modeling, and comparative analysis. Here we...
10.
Peterson J, Thor S, Kohler L, Kohler P, Metcalf W, Luthey-Schulten Z
BMC Genomics
. 2016 Nov;
17(1):924.
PMID: 27852217
Background: While a few studies on the variations in mRNA expression and half-lives measured under different growth conditions have been used to predict patterns of regulation in bacterial organisms, the...